Page 54 - ARNM-2-3

Advances in Radiotherapy
& Nuclear Medicine Image-guided interventional radiotherapy

24. Krzysztofiak T, Suchorzepka M, Tukiendorf A, Wojcieszek P, doi: 10.4103/jcrt.JCRT_434_19
Kamińska-Winciorek G. Basal cell carcinoma after high dose 34. Luo YJ, Liu ZL, Ye PC, et al. Safety and efficacy of
rate brachytherapy: Medium-term dermoscopic evaluation of intraoperative iodine-125 seed implantation brachytherapy
cancer’s response. Dermatol Ther (Heidelb). 2023;13:2063-2078.
for rectal cancer patients: A retrospective clinical research.
doi: 10.1007/s13555-023-00981-5 J Gastroenterol Hepatol. 2016;31:1076-1084.
25. Yamazaki H, Masui K, Suzuki G, et al. Reirradiation for doi: 10.1111/jgh.13261
recurrent head and neck carcinoma using high-dose-rate 35. Wang J, Yuan H, Ma Q, et al. Interstitial 125I seeds
brachytherapy: A multi-institutional study. Brachytherapy. implantation to treat spinal metastatic and primary
2022;21:341-346. paraspinal malignancies. Med Oncol. 2010;27:319-326.
doi: 10.1016/j.brachy.2021.12.011 doi: 10.1007/s12032-009-9212-1
26. Dankulchai P, Petsuksiri J, Chansilpa Y, Hoskin PJ. Image- 36. Jiang YL, Ji Z, Tian SQ, et al. CT-guidance interstitial
guided high-dose-rate brachytherapy in inoperable Iodine-125 seed brachytherapy as a salvage therapy for
endometrial cancer. Br J Radiol. 2014;87:20140018. recurrent head and neck carcinoma. Zhonghua yi xue za zhi.
doi: 10.1259/bjr.20140018 2018;98:3686-3691.
27. Henry A, Pieters BR, André Siebert F, Hoskin P. GEC-ESTRO doi: 10.3760/cma.j.issn.0376-2491.2018.45.011
ACROP prostate brachytherapy guidelines. Radiother Oncol. 37. Wang H, Wang J, Jiang Y, et al. The investigation of 125 I
2022;167:244-251. seed implantation as a salvage modality for unresectable
doi: 10.1016/j.radonc.2021.12.047 pancreatic carcinoma. J Exp Clin Cancer Res. 2013;32:106.
28. Sanmamed N, Lee J, Berlin A, et al. Tumor-targeted dose doi: 10.1186/1756-9966-32-106
escalation for localized prostate cancer using MR-guided 38. Wang JJ, Yuan HS, Li JN, Jiang YL, Tian SQ, Yang RJ. CT-guided
HDR brachytherapy (HDR) or integrated VMAT radioactive seed implantation for recurrent rectal carcinoma
(IB-VMAT) boost: Dosimetry, toxicity and health related after multiple therapy. Med Oncol. 2010;27:421-429.
quality of life. Radiother Oncol. 2020;149:240-245.
doi: 10.1007/s12032-009-9227-7
doi: 10.1016/j.radonc.2020.05.029
39. Huang M, Lin Q, Wang H, et al. Survival benefit of
29. Corkum M, Loblaw A, Hasan Y, et al. Prostate high dose- chemoembolization plus Iodine125 seed implantation in
rate brachytherapy as monotherapy for prostate cancer: Late unresectable hepatitis B-related hepatocellular carcinoma
toxicity and patient reported outcomes from a randomized with PVTT: A retrospective matched cohort study. Eur
phase II clinical trial. Radiother Oncol. 2021;156:160-165. Radiol. 2016;26:3428-3436.
doi: 10.1016/j.radonc.2020.12.021 doi: 10.1007/s00330-015-4198-x
30. Alayed Y, Loblaw A, McGuffin M, et al. Single-fraction HDR 40. Yang M, Fang Z, Yan Z, et al. Transarterial chemoembolisation
brachytherapy as monotherapy in low and intermediate (TACE) combined with endovascular implantation of an
risk prostate cancer: Outcomes from two clinical trials iodine-125 seed strand for the treatment of hepatocellular
with and without an MRI-guided boost. Radiother Oncol. carcinoma with portal vein tumour thrombosis versus
2021;154:29-35. TACE alone: A two-arm, randomised clinical trial. J Cancer
doi: 10.1016/j.radonc.2020.09.007 Res Clin Oncol. 2014;140:211-219.
31. Chin J, Rumble RB, Kollmeier M, et al. Brachytherapy for doi: 10.1007/s00432-013-1568-0
patients with prostate cancer: American Society of Clinical 41. Sun H, Zhang M, Liu R, Liu Y, Hou Y, Wu C. Endovascular
Oncology/Cancer Care Ontario Joint Guideline Update. implantation of 125 I seed combined with transcatheter
J Clin Oncol. 2017;35:1737-1743. arterial chemoembolization for unresectable hepatocellular
doi: 10.1200/jco.2016.72.0466 carcinoma. Future Oncol. 2018;14:1165-1176.
doi: 10.2217/fon-2017-0354
32. Mohler JL, Antonarakis ES. NCCN guidelines updates:
Management of prostate cancer. J Natl Compr Canc Netw. 42. Mo Z, Zhang T, Zhang Y, et al. Feasibility and clinical value
2019;17:583-586. of CT-guided 125 I brachytherapy for metastatic soft tissue
sarcoma after first-line chemotherapy failure. Eur Radiol.
doi: 10.6004/jnccn.2019.5011
2018;28:1194-1203.
33. Wang J, Chai S, Wang R, et al. Expert consensus on computed
tomography-assisted three-dimensional-printed coplanar doi: 10.1007/s00330-017-5036-0
template guidance for interstitial permanent radioactive I seed 43. Qu A, Jiang P, Sun H, et al. Efficacy and dosimetry analysis of
125
implantation therapy. J Cancer Res Ther. 2019;15:1430-1434. image-guided radioactive ¹²⁵I seed implantation as salvage

Volume 2 Issue 3 (2024) 9 doi: 10.36922/arnm.3781